Sidana, S., Martínez-López, J., Khan, A. M., Oriol, A., Spencer, A., Dhakal, B., Cohen, Y. C., Touzeau, C., Dytfeld, D., Einsele, H., San-Miguel, J., Manier, S., Chen, Y., Li, K., Benachour, N., Lonardi, C., Ghosh, A., Patel, N., Florendo, E., Harrison, S. J. (2025). Ciltacabtagene autoleucel (cilta-cel) vs standard of care (SOC) in patients (pts) with relapsed/refractory multiple myeloma (MM): CARTITUDE-4 survival subgroup analyses.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.7539